Fulton Breakefield Broenniman’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $30.2M | Sell |
|
|||||
|
2025
Q2 | $31.6M | Sell |
|
|||||
|
2025
Q1 | $33.6M | Sell |
|
|||||
|
2024
Q4 | $32.9M | Sell |
|
|||||
|
2024
Q3 | $37.8M | Sell |
|
|||||
|
2024
Q2 | $39.5M | Sell |
|
|||||
|
2024
Q1 | $34.2M | Sell |
|
|||||
|
2023
Q4 | $32.6M | Sell |
|
|||||
|
2023
Q3 | $30.4M | Sell |
|
|||||
|
2023
Q2 | $26.9M | Sell |
|
|||||
|
2023
Q1 | $23.6M | Sell |
|
|||||
|
2022
Q4 | $25.5M | Buy |
|
|||||
|
2022
Q3 | $22.5M | Sell |
|
|||||
|
2022
Q2 | $26.1M | Sell |
|
|||||
|
2022
Q1 | $25.4M | Buy |
|
|||||
|
2021
Q4 | $24.2M | Buy |
|
|||||
|
2021
Q3 | $19.9M | Sell |
|
|||||
|
2021
Q2 | $19.9M | Sell |
|
|||||
|
2021
Q1 | $23.9M | Buy |
|
|||||
|
2020
Q4 | $17.8M | Sell |
|
|||||
|
2020
Q3 | $17.9M | Buy |
|
|||||
|
2020
Q2 | $15.8M | Buy |
|
|||||
|
2020
Q1 | $12.8M | Buy |
|
|||||
|
2019
Q4 | $11.8M | Buy |
|
|||||
|
2019
Q3 | $9.89M | Buy |
|